or Try an Advanced Search...

    Technical Analysis for PSNL - Personalis, Inc.

    Grade Last Price % Change Price Change
    F 1.20 2.14% 0.03
    PSNL closed up 2.14 percent on Monday, July 1, 2024, on 1.16 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical PSNL trend table...
    Date Alert Name Type % Chg
    Hammer Candlestick Bullish 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    180 Bearish Setup Bearish Swing Setup 2.14%
    Gapped Up Strength 2.14%
    Oversold Stochastic Weakness 2.14%
    Stochastic Buy Signal Bullish -1.24%
    Oversold Stochastic Weakness -1.24%
    BB Squeeze Ended Range Expansion 0.84%
    Oversold Stochastic Weakness 0.84%
    Older End-of-Day Signals for PSNL ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace about 7 hours ago
    Down 2 % about 8 hours ago
    Down 1% about 8 hours ago
    Bearish 180 Entry about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PSNL Chart by TradingView
    Basic chart:

    Profile

    Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Data Analysis Services Cancer Therapy Oncogenomics Treating Cancer

    Is PSNL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 18 Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
    Jun 13 Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
    Jun 4 ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
    May 31 Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
    May 22 Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
    May 9 Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript
    May 9 Is Personalis (NASDAQ:PSNL) In A Good Position To Deliver On Growth Plans?
    May 9 Personalis First Quarter 2024 Earnings: US$0.26 loss per share (vs US$0.61 loss in 1Q 2023)
    May 9 Q1 2024 Personalis Inc Earnings Call
    May 9 Personalis Inc (PSNL) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Revenue ...
    See more PSNL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.41
    52 Week Low 0.8912
    Average Volume 222,536
    200-Day Moving Average 1.39
    50-Day Moving Average 1.38
    20-Day Moving Average 1.29
    10-Day Moving Average 1.22
    Average True Range 0.09
    RSI (14) 39.76
    ADX 18.23
    +DI 18.07
    -DI 19.53
    Chandelier Exit (Long, 3 ATRs) 1.33
    Chandelier Exit (Short, 3 ATRs) 1.41
    Upper Bollinger Bands 1.47
    Lower Bollinger Band 1.12
    Percent B (%b) 0.21
    BandWidth 26.74
    MACD Line -0.06
    MACD Signal Line -0.05
    MACD Histogram -0.0085
    Fundamentals Value
    Market Cap 58.59 Million
    Num Shares 49 Million
    EPS -2.38
    Price-to-Earnings (P/E) Ratio -0.50
    Price-to-Sales 0.83
    Price-to-Book 0.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.32
    Resistance 3 (R3) 1.32 1.27 1.30
    Resistance 2 (R2) 1.27 1.24 1.27 1.29
    Resistance 1 (R1) 1.23 1.22 1.21 1.24 1.29
    Pivot Point 1.18 1.18 1.17 1.19 1.18
    Support 1 (S1) 1.15 1.15 1.12 1.15 1.10
    Support 2 (S2) 1.10 1.13 1.10 1.10
    Support 3 (S3) 1.06 1.10 1.09
    Support 4 (S4) 1.07